ACRP blog
NOVEMBER 8, 2023
As several retail pharmacy chains proclaim a rosy outlook for ongoing efforts to expand their services into the clinical trials arena in the wake of the pandemic, traditional study site personnel and patients interviewed on the topic offered more mixed and nuanced concerns about the prospects for near-term success for such ventures.
ACRP blog
NOVEMBER 8, 2023
As several retail pharmacy chains proclaim a rosy outlook for ongoing efforts to expand their services into the clinical trials arena in the wake of the pandemic, traditional study site personnel and patients interviewed on the topic offered more mixed and nuanced concerns about the prospects for near-term success for such ventures.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
DECEMBER 28, 2020
Prior to that, Dr. Zhang was an equity research analyst at UBS in New York , where he covered the Major and Specialty Pharmaceutical Sector. in its healthcare practice and conducted postdoctoral research in diabetes-related drug development at Boston University’s School of Medicine. .”
The Pharma Data
DECEMBER 31, 2020
where he led global clinical development programs including clinical strategy, clinical development, and regulatory affairs. Prior to Taiho, he held the positions of senior vice president of Clinical Oncology and CMO at Geron Corporation. and CMO for Taiho Oncology, Inc.
XTalks
OCTOBER 13, 2020
The US FDA also outlined advice to developers looking to get emergency use authorizations (EUA) in a guidance document that it released last week. As part of its efforts, the agency has plans to conduct a meeting for independent experts to review overall progress on coronavirus vaccine development. Just another political hit job!
Expert insights. Personalized for you.
59 
Let's personalize your content